Nature Communications (Feb 2022)

Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology

  • C. Wittenbecher,
  • R. Cuadrat,
  • L. Johnston,
  • F. Eichelmann,
  • S. Jäger,
  • O. Kuxhaus,
  • M. Prada,
  • F. Del Greco M.,
  • A. A. Hicks,
  • P. Hoffman,
  • J. Krumsiek,
  • F. B. Hu,
  • M. B. Schulze

DOI
https://doi.org/10.1038/s41467-022-28496-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 13

Abstract

Read online

Among lipid classes, ceramides are linked to impaired cardiometabolic health. Here the authors report the association of specific ceramides and dihydroceramides on the risk of developing type 2 diabetes and or cardiovascular disease in a prospective population cohort.